scholarly article | Q13442814 |
P819 | ADS bibcode | 2006Sci...311.1474S |
P356 | DOI | 10.1126/SCIENCE.1121176 |
P698 | PubMed publication ID | 16456039 |
P5875 | ResearchGate publication ID | 7318281 |
P50 | author | Catherine Hankins | Q30513822 |
Joshua A Salomon | Q37607615 | ||
Juan Pablo Gutiérrez | Q57318122 | ||
Stefano Bertozzi | Q92658759 | ||
P2093 | author name string | Neff Walker | |
John Stover | |||
Robert Greener | |||
Peter D Ghys | |||
Geoff P Garnett | |||
J Ties Boerma | |||
Eleanor Gouws | |||
Paul De Lay | |||
Karen A Stanecki | |||
P433 | issue | 5766 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV/AIDS | Q12199 |
prevention | Q1717246 | ||
prevention of HIV/AIDS | Q7242372 | ||
P304 | page(s) | 1474-1476 | |
P577 | publication date | 2006-02-02 | |
P1433 | published in | Science | Q192864 |
P1476 | title | The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries | |
P478 | volume | 311 |
Q34470827 | A comparison of HIV detection rates using routine opt-out provider-initiated HIV testing and counseling versus a standard of care approach in a rural African setting |
Q34919727 | A novel approach to accounting for loss to follow-up when estimating the relationship between CD4 Count at ART initiation and mortality |
Q37798411 | AIDS in Asia amid competing priorities: a review of national responses to HIV |
Q36557334 | AIDS: from crisis management to sustained strategic response |
Q30394616 | Asia can afford universal access for AIDS prevention and treatment |
Q35591286 | Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention |
Q64055640 | Assessing the cost of providing a prevention of mother-to-child transmission of HIV/AIDS service in Ethiopia: urban-rural health facilities setting |
Q30414374 | Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis |
Q46313407 | Can epidemiology inform global health and development targets? |
Q30892349 | Can we spend our way out of the AIDS epidemic? A world halting AIDS model |
Q36089732 | Changes in HIV risk behavior and seroincidence among clients presenting for repeat HIV counseling and testing in Moshi, Tanzania |
Q36944602 | Changing cost of HIV interventions in the context of scaling-up in India |
Q37456027 | Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania |
Q58924950 | Coming to terms with complexity: a call to action for HIV prevention |
Q36548078 | Containing HIV/AIDS in India: the unfinished agenda |
Q33267835 | Cost-effectiveness of male circumcision for HIV prevention in a South African setting |
Q35794458 | Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease |
Q35729350 | Decision making for HIV prevention and treatment scale up: bridging the gap between theory and practice |
Q33504903 | Determining a cost effective intervention response to HIV/AIDS in Peru |
Q36941573 | Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies |
Q38114142 | Economic evaluations of point of care testing strategies for active tuberculosis |
Q21144661 | Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review |
Q34766899 | Estimating the 2006 prevalence of HIV by gender and risk groups in Tijuana, Mexico |
Q36941015 | Estimating the number of HIV infections averted: an approach and its issues |
Q37063081 | Estimating the resources required in the roll-out of universal access to antiretroviral treatment in Zimbabwe |
Q41471847 | Estimating trends in life expectancy in HIV-positive individuals |
Q37085142 | Global Fund-supported programmes contribution to international targets and the Millennium Development Goals: an initial analysis |
Q30410700 | Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. |
Q30892555 | HIV prevention cost-effectiveness: a systematic review |
Q31118706 | HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries |
Q36958230 | Improving analysis of the size and dynamics of AIDS epidemics |
Q39605470 | Inexpensive designer antigen for anti-HIV antibody detection with high sensitivity and specificity. |
Q33569197 | Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007. |
Q33952153 | Long-term costs and health impact of continued global fund support for antiretroviral therapy |
Q33833876 | Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe |
Q37203626 | Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis |
Q28535033 | Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women |
Q33299456 | Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings |
Q46395904 | Routine testing for HIV/AIDS in sub-Saharan Africa: a philosopher's perspective |
Q36661454 | S4HARA: System for HIV/AIDS resource allocation |
Q37605568 | Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations |
Q92661710 | The Big Four: Functional Assessment Research Informs Preventative Behavior Analysis |
Q37428151 | The costs of a sexually transmitted infection outreach and treatment programme targeting most at risk youth in Tajikistan |
Q34155879 | The costs of scaling up HIV prevention for high risk groups: lessons learned from the Avahan Programme in India |
Q35656683 | The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India |
Q36821667 | The future of HIV prevention: control of sexually transmitted infections and circumcision interventions |
Q33323442 | The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling |
Q28484308 | The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study |
Q22241890 | The spread, treatment, and prevention of HIV-1: evolution of a global pandemic |
Q49100701 | The welfare costs of HIV/AIDS in eastern Europe: an empirical assessment using the economic value-of-life approach |
Q37182088 | Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy? |
Q33336557 | Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa |
Q91913016 | What is global health? Key concepts and clarification of misperceptions: Report of the 2019 GHRP editorial meeting |
Q26826936 | World health dilemmas: Orphan and rare diseases, orphan drugs and orphan patients |
Search more.